RECOMBINATE
antihemophilic factor recombinant · KIT · Takeda Pharmaceuticals America, Inc.
RECOMBINATE is a kit containing antihemophilic factor recombinant. Manufactured by Takeda Pharmaceuticals America, Inc..
Key Facts
- Brand Name
- RECOMBINATE
- Generic Name
- antihemophilic factor recombinant
- NDC Code (Product)
0944-2845- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA103375
- Marketing Start
- 03/15/2010
Recall History
Cardinal Health Inc.
CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.
Frequently Asked Questions
What is RECOMBINATE used for?
RECOMBINATE contains antihemophilic factor recombinant. It is a kit taken as directed. Consult your doctor for specific uses.
Is RECOMBINATE a controlled substance?
RECOMBINATE is not classified as a controlled substance by the DEA.
What is the generic name for RECOMBINATE?
The generic name for RECOMBINATE is antihemophilic factor recombinant. There are 6 other brand versions of antihemophilic factor recombinant.
What is the NDC code for RECOMBINATE ?
The NDC (National Drug Code) for RECOMBINATE is 0944-2845, listed by Takeda Pharmaceuticals America, Inc..